Premia Spine
10 articles about Premia Spine
-
Premia Spine Completes FDA Site Inspections With No FDA Observations
4/13/2023
Premia Spine today announced the U.S. Food and Drug Administration (FDA) has completed four Bioresearch Monitoring (BIMO) inspections as part of the PMA approval process for the TOPS facet joint replacement system.
-
Premia Spine’s TOPS™ Facet Joint Replacement Demonstrates Significant Improvement in All Patient-Reported Outcome Measures Versus Fusion in FDA Trial
2/28/2023
Premia Spine today announced publication of two-year outcomes from the TOPS facet joint replacement system’s clinical trial in the Journal of Neurosurgery Spine.
-
Premia Spine’s TOPS™ Facet Replacement Demonstrates Significant Improvement in All Patient-Reported Outcome Measures in FDA Trial
10/19/2022
Premia Spine today announced publication of one-year outcomes from the TOPS facet replacement system’s clinical trial in the journal Clinical Spine Surgery . The study, “ A Prospective Study of Lumbar Facet Arthroplasty in the Treatment of degenerative Spondylolisthesis and Stenosis: Results from the Total Posterior Spine System (TOPS) IDE Study.
-
Study Data Show Premia Spine’s TOPS™ Spinal Arthroplasty System Is Cost-effective Compared With TLIF, Becomes Dominant Strategy Over Time
6/2/2022
First-of-a-kind TOPS System designed to offer treatment alternative for patients with spinal stenosis and spondylolisthesis.
-
Premia Spine Appoints Three New Board Advisors
12/8/2021
Premia Spine today announced the appointment of three new advisors to its board of directors.
-
Premia Spine’s TOPS™ Spinal Arthroplasty System Yields Positive Patient Outcomes at 6 Weeks Through 12 Months
11/4/2021
Premia Spine, a medical technology company aiming to change the way debilitating chronic leg and back pain is treated, announced that intermediate clinical study results supporting the use of its TOPS™ facet arthroplasty system for lumbar spinal stenosis and degenerative spondylolisthesis were presented at the 2021 Society for Minimally Invasive Spine Surgery meeting in Las Vegas by Dr.
-
Premia Spine Announces Growing Body of Clinical and Economic Data Supporting Its TOPS Spinal Arthroplasty System
7/22/2021
Premia Spine today announced a growing foundation of clinical and economic evidence supporting its TOPS facet arthroplasty system,
-
Premia Spine Announces FDA Breakthrough Device Designation for Its TOPS™ Spinal Arthroplasty System
3/31/2021
Premia Spine , a medical technology company aiming to change the way debilitating chronic leg and back pain is treated, today announced that its TOPS facet arthroplasty system won Breakthrough Device Designation from the U.S. Food & Drug Administration.
-
Premia Spine Launches ProMIS Fixation System
4/5/2016
-
Premia Spine Confirms $7 Million Raise For Spinal Fusion Alternative
6/2/2014